Camp Spike & Wave - Day 3

Another great day! (and a later night!)
The high ropes course is definitely a camp highlight!
Horse riding is wonderful.  Can we get ponies when we come home?
Smores - a great way to end a fun day!

Climbing the cargo net

What a great view!

Gimme 5!

Working together

Keep your balance!

New recruits?

More balancing acts

Giddyup!

Hey cowby!

Camp Spike & Wave - Day 2

Ah, the fun has begun!

We started out our day in a great way - climbing the rock wall.  The kids are quite the squirrels - many made it all the way to the top to ding the bell - 32 feet up!  Cycling was on the schedule as well today.  No, we didn't just ride regular old two-wheel bikes.  We got to try out adaptive bikes - so cool!  Crafts, you bet!  We made bottle cap necklaces, I-Spy bottles, and tie-dyed t-shirts.  The Lynch family came up to volunteer for the day.  We played a great game of Sardines with them and had fun with them at the pool.  Their fundraiser, Laps for Lyndsay, helped with camp tuition this year.  Thanks, Lynches!  We ended the day at the Kamas Rec Center pool.  Do we have to get out???

Biking - the good life!

Tie-dying - not as messy as you'd think!

What a great way to cool off!

Waiting our turns and planning out our routes to the top!

Blindfolded?  Piece of cake!

Easy does it!

Biking

The Lynch Family

The gang's all here!

Camp Spike & Wave - Day 1

Well, we're here!  We got a taste of the fun we're going to have - and now we're ready to have fun tomorrow, Friday, and Saturday!
Dinner from Madeline's was great - thanks!
"Flight of the Navigator" was the feature of movie night - check it out!

Checking out the campus.  Look at that ropes course we'll be on by the end of the week!

Visiting with the horses.

Telling stories.

More story telling.

Upsher-Smith Laboratories Begins Phase III Study Of Intranasal Midazolam For Rescue Treatment Of Seizure Clusters In Epilepsy Patients

Upsher-Smith Laboratories, Inc. announced the initiation of a Phase III clinical trial to evaluate the safety and efficacy of USL261, an investigational intranasal midazolam, for the rescue treatment of seizures in patients on stable anti-epileptic drug (AED) regimens who require control of intermittent bouts of increased seizure activity, frequently referred to as seizure clusters. USL261 has been granted orphan drug designation for this use by the Food and Drug Administration (FDA).

Upsher-Smith Laboratories Begins Phase III Study Of Intranasal Midazolam For Rescue Treatment Of Seizure Clusters In Epilepsy Patients

Greater seizure frequency seen in women with epilepsy during anovulatory cycle

Greater seizure frequency seen in women with epilepsy during anovulatory cycle